id,sequence,label,elisa_flags,source
abituzumab,QQGNTFPYT,0.0,0,jain2017_pnas
abrilumab,QQANSFPWT,0.0,0,jain2017_pnas
adalimumab,QRYNRAPYT,0.0,0,jain2017_pnas
alemtuzumab,LQHISRPRT,0.0,0,jain2017_pnas
alirocumab,QQYYTTPYT,0.0,0,jain2017_pnas
anifrolumab,QQYDSSAIT,0.0,0,jain2017_pnas
atezolizumab,QQYLYHPAT,0.0,0,jain2017_pnas
bapineuzumab,WQGTHFPRT,0.0,0,jain2017_pnas
basiliximab,HQRSSYT,0.0,0,jain2017_pnas
bavituximab,LQYVSSPPT,0.0,0,jain2017_pnas
belimumab,SSRDSSGNHWV,1.0,6,jain2017_pnas
benralizumab,QQGYTLPYT,0.0,0,jain2017_pnas
bevacizumab,QQYSTVPWT,0.0,0,jain2017_pnas
bimagrumab,GTFAGGSYYGV,0.0,0,jain2017_pnas
blosozumab,QQYSDYPWT,1.0,6,jain2017_pnas
bococizumab,QQRYSLWRT,1.0,6,jain2017_pnas
brentuximab,QQSNEDPWT,,3,jain2017_pnas
briakinumab,QSYDRYTHPALL,1.0,4,jain2017_pnas
brodalumab,QQYDNWPLT,,1,jain2017_pnas
canakinumab,HQSSSLPFT,0.0,0,jain2017_pnas
carlumab,HQYIQLHSFT,1.0,4,jain2017_pnas
certolizumab,QQYNIYPLT,0.0,0,jain2017_pnas
cetuximab,QQNNNWPTT,0.0,0,jain2017_pnas
cixutumumab,KSRDGSGQHLV,1.0,6,jain2017_pnas
clazakizumab,QQGYSLRNIDNA,0.0,0,jain2017_pnas
codrituzumab,SQNTHVPPT,1.0,6,jain2017_pnas
crenezumab,SQSTHVPWT,0.0,0,jain2017_pnas
dacetuzumab,SQTTHVPWT,0.0,0,jain2017_pnas
daclizumab,HQRSTYPLT,,1,jain2017_pnas
dalotuzumab,FQGSHVPWT,1.0,5,jain2017_pnas
daratumumab,QQRSNWPPT,0.0,0,jain2017_pnas
denosumab,QQYGSSPRT,1.0,5,jain2017_pnas
dinutuximab,SQSTHVPPLT,0.0,0,jain2017_pnas
drozitumab,NSADSSGNHVV,0.0,0,jain2017_pnas
duligotuzumab,QQSEPEPYT,1.0,6,jain2017_pnas
dupilumab,MQALQTPYT,1.0,5,jain2017_pnas
eculizumab,QNVLNTPLT,0.0,0,jain2017_pnas
efalizumab,QQHNEYPLT,0.0,0,jain2017_pnas
eldelumab,QQYGSSPIFT,0.0,0,jain2017_pnas
elotuzumab,QQYSSYPYT,0.0,0,jain2017_pnas
emibetuzumab,QVYSGYPLT,1.0,6,jain2017_pnas
enokizumab,QQFYEYPLT,0.0,0,jain2017_pnas
epratuzumab,HQYLSSWT,,1,jain2017_pnas
etrolizumab,QQGNSLPNT,,2,jain2017_pnas
evolocumab,NSYTSTSMV,,2,jain2017_pnas
farletuzumab,QQWSSYPYMYT,0.0,0,jain2017_pnas
fasinumab,QQYNRYPWT,0.0,0,jain2017_pnas
fezakinumab,QSYDNSLSGYV,0.0,0,jain2017_pnas
ficlatuzumab,GQSYNYPYT,0.0,0,jain2017_pnas
figitumumab,LQHNSYPCS,,3,jain2017_pnas
fletikumab,QQFNSYPLT,0.0,0,jain2017_pnas
foralumab,QQRSNWPPLT,,2,jain2017_pnas
fresolimumab,QQYADSPIT,0.0,0,jain2017_pnas
fulranumab,QQFNSYPLT,,1,jain2017_pnas
galiximab,QSYDSSLNAQV,0.0,0,jain2017_pnas
ganitumab,MQGTHWPLT,0.0,0,jain2017_pnas
gantenerumab,LQIYNMPIT,1.0,6,jain2017_pnas
gemtuzumab,QQTKEVPWS,0.0,0,jain2017_pnas
gevokizumab,LQGKMLPWT,0.0,0,jain2017_pnas
girentuximab,QQYSNYPWT,0.0,0,jain2017_pnas
glembatumumab,QQYNNWPPWT,0.0,0,jain2017_pnas
golimumab,QQRSNWPPFT,,1,jain2017_pnas
guselkumab,ASWTDGLSLVV,,1,jain2017_pnas
ibalizumab,QQYYSYRT,0.0,0,jain2017_pnas
imgatuzumab,LQHNSFPT,1.0,5,jain2017_pnas
infliximab,QQSHSWPFT,0.0,0,jain2017_pnas
inotuzumab,LQGTHQPYT,,3,jain2017_pnas
ipilimumab,QQYGSSPWT,0.0,0,jain2017_pnas
ixekizumab,SQSTHLPFT,1.0,6,jain2017_pnas
lampalizumab,LQSDSLPYT,0.0,0,jain2017_pnas
lebrikizumab,QQNNEDPRT,0.0,0,jain2017_pnas
lenzilumab,QQFNKSPLT,1.0,6,jain2017_pnas
lintuzumab,QQSKEVPWT,0.0,0,jain2017_pnas
lirilumab,QQRSNWMYT,0.0,0,jain2017_pnas
lumiliximab,LQVYSTPRT,0.0,0,jain2017_pnas
matuzumab,QQWSSHIFT,0.0,0,jain2017_pnas
mavrilimumab,ATVEAGLSGSV,0.0,0,jain2017_pnas
mepolizumab,QNVHSFPFT,0.0,0,jain2017_pnas
mogamulizumab,FQGSLLPWT,0.0,0,jain2017_pnas
motavizumab,FQGSGYPFT,,1,jain2017_pnas
muromonab,QQWSSNPFT,0.0,0,jain2017_pnas
natalizumab,LQYDNLWT,0.0,0,jain2017_pnas
necitumumab,HQYGSTPLT,0.0,0,jain2017_pnas
nimotuzumab,FQYSHVPWT,0.0,0,jain2017_pnas
nivolumab,QQSSNWPRT,0.0,0,jain2017_pnas
obinutuzumab,AQNLELPYT,0.0,0,jain2017_pnas
ocrelizumab,QQWSFNPPT,0.0,0,jain2017_pnas
ofatumumab,QQRSNWPIT,0.0,0,jain2017_pnas
olaratumab,QQRSNWPPA,0.0,0,jain2017_pnas
olokizumab,LQHNSAPYT,0.0,0,jain2017_pnas
omalizumab,QQSHEDPYT,0.0,0,jain2017_pnas
onartuzumab,QQYYAYPWT,0.0,0,jain2017_pnas
otelixizumab,HSYVSSFNV,0.0,0,jain2017_pnas
otlertuzumab,QHHSDNPWT,0.0,0,jain2017_pnas
ozanezumab,QQLVEYPLT,,3,jain2017_pnas
palivizumab,FQGSGYPFT,0.0,0,jain2017_pnas
panitumumab,QHFDHLPLA,0.0,0,jain2017_pnas
panobacumab,MQGTHWPLT,0.0,0,jain2017_pnas
parsatuzumab,GQSTHVPLT,1.0,6,jain2017_pnas
patritumab,QQYYSTPRT,1.0,4,jain2017_pnas
pembrolizumab,QHSRDLPLT,0.0,0,jain2017_pnas
pertuzumab,QQYYIYPYT,0.0,0,jain2017_pnas
pinatuzumab,FQGSQFPYT,0.0,0,jain2017_pnas
polatuzumab,QQSNEDPLT,0.0,0,jain2017_pnas
ponezumab,LQGTHYPVL,1.0,4,jain2017_pnas
radretumab,QQTGRIPPT,0.0,0,jain2017_pnas
ramucirumab,QQAKAFPPT,0.0,0,jain2017_pnas
ranibizumab,QQYSTVPWT,,1,jain2017_pnas
reslizumab,QQSYKFPNT,0.0,0,jain2017_pnas
rilotumumab,QQYINWPPIT,0.0,0,jain2017_pnas
rituximab,QQWTSNPPT,0.0,0,jain2017_pnas
robatumumab,HQSSRLPHT,1.0,4,jain2017_pnas
romosozumab,QQGDTLPYT,0.0,0,jain2017_pnas
sarilumab,QQANSFPYT,0.0,0,jain2017_pnas
secukinumab,QQYGSSPCT,0.0,0,jain2017_pnas
seribantumab,CSYAGSSIFVI,0.0,0,jain2017_pnas
sifalimumab,QQYGSSPRT,,3,jain2017_pnas
siltuximab,QQWSGYPYT,0.0,0,jain2017_pnas
simtuzumab,MQHLEYPYT,1.0,6,jain2017_pnas
sirukumab,MQWSGYPYT,1.0,5,jain2017_pnas
tabalumab,QQRSNWPRT,0.0,0,jain2017_pnas
tanezumab,QQEHTLPYT,,1,jain2017_pnas
teplizumab,QQWSSNPFT,,2,jain2017_pnas
tigatuzumab,QQYSSYRT,0.0,0,jain2017_pnas
tildrakizumab,QHHYGIPFT,0.0,0,jain2017_pnas
tocilizumab,QQGNTLPYT,0.0,0,jain2017_pnas
tovetumab,QQTYSNPPIT,0.0,0,jain2017_pnas
tralokinumab,QVWDTGSDPVV,0.0,0,jain2017_pnas
trastuzumab,QQHYTTPPT,0.0,0,jain2017_pnas
tremelimumab,QQYYSTPFT,0.0,0,jain2017_pnas
urelumab,QQRSNWPPALT,0.0,0,jain2017_pnas
ustekinumab,QQYNIYPYT,,3,jain2017_pnas
vedolizumab,LQGTHQPYT,0.0,0,jain2017_pnas
veltuzumab,QQWTSNPPT,0.0,0,jain2017_pnas
visilizumab,QQWSSNPPT,,3,jain2017_pnas
zalutumumab,QQFNSYPLT,,1,jain2017_pnas
zanolimumab,QQANSFPYT,0.0,0,jain2017_pnas
